Adherium (ASX:ADR) said it has received firm commitments for AU$2.6 million convertible notes to support the roll-out of its proprietary Hailie Smartinhaler platform in the US, according to a Tuesday Australian bourse filing.
The capital raise is expected to issue 2.6 million convertible notes maturing in nine months at an interest of 10% per year. Participants will also receive one attached option per two shares subscribed.
PAC Partners and Stralis Capital were the joint lead managers for the capital raise.
The company reaffirmed its guidance to onboard another 1,800 active patients during the next six months and 9,000 active patients by the end of the year.
Its shares rose 10% on market close.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.